With an upside potential of 843.40%, Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) is among the 7 Best Rated Penny Stocks to Buy ...

The jump in price for CTXR stock comes alongside an increase in trading. As of this writing, more than 84 million shares of the stock have changed hands. For some context, the company’s daily average ...

View Citius Pharmaceuticals Inc CTXR stock quote prices, financial information, real-time forecasts, and company news from CNN.

The average one-year price target for Citius Pharmaceuticals (NasdaqCM:CTXR) has been revised to $6.12 / share. This is an increase of 20.00% from the prior estimate of $5.10 dated April 25, 2026. The ...

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) shares jumped 22.12% in after-hours trading to $1.27 on Tuesday, following the company’s fiscal year 2025 business update and the commercial launch of its ...

Citius Pharmaceuticals Inc. (NASDAQ:CTXR) is one of the stocks that should double in 3 years. On February 13, Citius Pharmaceuticals officially transitioned into a revenue-generating company following ...

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than ...

Citius Pharmaceuticals Inc. Annual cash flow by MarketWatch. View CTXR net cash flow, operating cash flow, operating expenses and cash dividends.